カテゴリ： Stratistics MRC, 世界, 医療/バイオ

高薬理活性医薬原体（HPAPI）の世界市場2019-2027

◆英語タイトル：High Potency Active Pharmaceutical Ingredient (HPAPI) - Global Market Outlook (2019-2027)
◆商品コード：SMRC20JL219
◆発行会社（リサーチ会社）：Stratistics MRC
◆発行日：2020年6月30日
◆ページ数：158
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single UserUSD4,150 ⇒換算￥435,750見積依頼/購入/質問フォーム
Five UserUSD5,250 ⇒換算￥551,250見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算￥787,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※Stratistics MRC社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
本調査レポートでは、高薬理活性医薬原体（HPAPI）の世界市場について調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、薬物種類別（新型、革新的、ジェネリック）分析、製造会社別分析、製品別分析、用途別分析、地域別分析、主要な市場開拓、企業情報などを含めており、以下の構成で提供いたします。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・高薬理活性医薬原体（HPAPI）の世界市場規模：薬物種類別（新型、革新的、ジェネリック）
・高薬理活性医薬原体（HPAPI）の世界市場規模：製造会社別
・高薬理活性医薬原体（HPAPI）の世界市場規模：製品別
・高薬理活性医薬原体（HPAPI）の世界市場規模：用途別
・高薬理活性医薬原体（HPAPI）の世界市場規模：地域別
・主要な市場開拓
・企業情報
【レポートの概要】

According to Stratistics MRC, the Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market is accounted for $20.39 billion in 2019 and is expected to reach $51.59 billion by 2027 growing at a CAGR of 12.3% during the forecast period. Rising R&D pertaining to anticancer drugs and increasing number of pharmaceutical industries are the major factors driving the market growth. However, lack of universal regulatory policies and standards is restraining the market growth.

High Potency API (HPAPI) can be defined as a pharmacologically intermediates or substances, active at concentrations of 150 micrograms per kilogram of body weight or beneath. They are generally highly selective and have the potential to bind to specific receptors or bind to specific enzymes which can cause cancer, developmental disorders, and reproductive issues at low dosages. Numerous new drugs have these high potency active pharmaceutical ingredients.

Based on application, the oncology segment is likely to have a huge demand due to rise in the introduction of advanced therapeutic options and increase in cancer cases across the globe. By geography, North America is going to have a lucrative growth during the forecast period due to the existence of developed biotech industries, rising cases of cancer, growth in rate of older age diseases along with changing lifestyle.

Some of the key players profiled in the High Potency Active Pharmaceutical Ingredient (HPAPI) Market include Abbvie, Alkermes plc, Bristol-Myers Squibb, Cambrex Corporation, Dr. Reddy’s Laboratories, Eli Lilly and Company, F. Hoffmann-La Roche, Lonza Group, Novartis AG, Novasep, Pfizer, Sigma-Aldrich Co LLC, Teva Pharmaceutical Industries and WuXi AppTec.

Drug Types Covered:
• Novel
• Innovative
• Generic

Manufacturer s Covered:
• Outsourced/ Contract
• In-house (Captive)

Products Covered:
• Biologic
• Biosimilar
• Biotech
• Synthetic

Applications Covered:
• Glaucoma
• Hormonal
• Infectious Diseases
• Inflammation
• Musculoskeletal Drugs
• Oncology
• Other Applications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client’s interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market, By Drug Type
5.1 Introduction
5.2 Novel
5.3 Innovative
5.4 Generic

6 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market, By Manufacturer
6.1 Introduction
6.2 Outsourced/ Contract
6.3 In-house (Captive)

7 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market, By Product
7.1 Introduction
7.2 Biologic
7.3 Biosimilar
7.4 Biotech
7.5 Synthetic

8 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market, By Application
8.1 Introduction
8.2 Glaucoma
8.3 Hormonal
8.4 Infectious Diseases
8.5 Inflammation
8.6 Musculoskeletal Drugs
8.7 Oncology
8.8 Other Applications
8.8.1 Anti-diabetic Drugs
8.8.2 Cardiovascular Drugs
8.8.3 Cosmetology
8.8.4 Erectile Dysfunction
8.8.5 Respiratory Disorders

9 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Abbvie
11.2 Alkermes plc
11.3 Bristol-Myers Squibb
11.4 Cambrex Corporation
11.5 Dr. Reddy’s Laboratories
11.6 Eli Lilly and Company
11.7 F. Hoffmann-La Roche
11.8 Lonza Group
11.9 Novartis AG
11.10 Novasep
11.11 Pfizer
11.12 Sigma-Aldrich Co LLC
11.13 Teva Pharmaceutical Industries
11.14 WuXi AppTec

List of Tables
Table 1 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Drug Type (2018-2027) ($MN)
Table 3 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Novel (2018-2027) ($MN)
Table 4 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Innovative (2018-2027) ($MN)
Table 5 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Generic (2018-2027) ($MN)
Table 6 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Manufacturer (2018-2027) ($MN)
Table 7 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Outsourced/ Contract (2018-2027) ($MN)
Table 8 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By In-house (Captive) (2018-2027) ($MN)
Table 9 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Product (2018-2027) ($MN)
Table 10 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biologic (2018-2027) ($MN)
Table 11 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biosimilar (2018-2027) ($MN)
Table 12 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biotech (2018-2027) ($MN)
Table 13 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Synthetic (2018-2027) ($MN)
Table 14 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Application (2018-2027) ($MN)
Table 15 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Glaucoma (2018-2027) ($MN)
Table 16 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Hormonal (2018-2027) ($MN)
Table 17 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Infectious Diseases (2018-2027) ($MN)
Table 18 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Inflammation (2018-2027) ($MN)
Table 19 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Musculoskeletal Drugs (2018-2027) ($MN)
Table 20 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Oncology (2018-2027) ($MN)
Table 21 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Other Applications (2018-2027) ($MN)
Table 22 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Anti-diabetic Drugs (2018-2027) ($MN)
Table 23 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Cardiovascular Drugs (2018-2027) ($MN)
Table 24 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Cosmetology (2018-2027) ($MN)
Table 25 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Erectile Dysfunction (2018-2027) ($MN)
Table 26 Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Respiratory Disorders (2018-2027) ($MN)
Table 27 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Country (2018-2027) ($MN)
Table 28 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Drug Type (2018-2027) ($MN)
Table 29 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Novel (2018-2027) ($MN)
Table 30 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Innovative (2018-2027) ($MN)
Table 31 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Generic (2018-2027) ($MN)
Table 32 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Manufacturer (2018-2027) ($MN)
Table 33 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Outsourced/ Contract (2018-2027) ($MN)
Table 34 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By In-house (Captive) (2018-2027) ($MN)
Table 35 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Product (2018-2027) ($MN)
Table 36 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biologic (2018-2027) ($MN)
Table 37 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biosimilar (2018-2027) ($MN)
Table 38 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biotech (2018-2027) ($MN)
Table 39 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Synthetic (2018-2027) ($MN)
Table 40 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Application (2018-2027) ($MN)
Table 41 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Glaucoma (2018-2027) ($MN)
Table 42 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Hormonal (2018-2027) ($MN)
Table 43 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Infectious Diseases (2018-2027) ($MN)
Table 44 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Inflammation (2018-2027) ($MN)
Table 45 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Musculoskeletal Drugs (2018-2027) ($MN)
Table 46 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Oncology (2018-2027) ($MN)
Table 47 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Other Applications (2018-2027) ($MN)
Table 48 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Anti-diabetic Drugs (2018-2027) ($MN)
Table 49 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Cardiovascular Drugs (2018-2027) ($MN)
Table 50 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Cosmetology (2018-2027) ($MN)
Table 51 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Erectile Dysfunction (2018-2027) ($MN)
Table 52 North America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Respiratory Disorders (2018-2027) ($MN)
Table 53 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Country (2018-2027) ($MN)
Table 54 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Drug Type (2018-2027) ($MN)
Table 55 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Novel (2018-2027) ($MN)
Table 56 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Innovative (2018-2027) ($MN)
Table 57 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Generic (2018-2027) ($MN)
Table 58 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Manufacturer (2018-2027) ($MN)
Table 59 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Outsourced/ Contract (2018-2027) ($MN)
Table 60 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By In-house (Captive) (2018-2027) ($MN)
Table 61 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Product (2018-2027) ($MN)
Table 62 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biologic (2018-2027) ($MN)
Table 63 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biosimilar (2018-2027) ($MN)
Table 64 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biotech (2018-2027) ($MN)
Table 65 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Synthetic (2018-2027) ($MN)
Table 66 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Application (2018-2027) ($MN)
Table 67 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Glaucoma (2018-2027) ($MN)
Table 68 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Hormonal (2018-2027) ($MN)
Table 69 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Infectious Diseases (2018-2027) ($MN)
Table 70 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Inflammation (2018-2027) ($MN)
Table 71 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Musculoskeletal Drugs (2018-2027) ($MN)
Table 72 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Oncology (2018-2027) ($MN)
Table 73 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Other Applications (2018-2027) ($MN)
Table 74 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Anti-diabetic Drugs (2018-2027) ($MN)
Table 75 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Cardiovascular Drugs (2018-2027) ($MN)
Table 76 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Cosmetology (2018-2027) ($MN)
Table 77 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Erectile Dysfunction (2018-2027) ($MN)
Table 78 Europe High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Respiratory Disorders (2018-2027) ($MN)
Table 79 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Country (2018-2027) ($MN)
Table 80 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Drug Type (2018-2027) ($MN)
Table 81 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Novel (2018-2027) ($MN)
Table 82 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Innovative (2018-2027) ($MN)
Table 83 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Generic (2018-2027) ($MN)
Table 84 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Manufacturer (2018-2027) ($MN)
Table 85 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Outsourced/ Contract (2018-2027) ($MN)
Table 86 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By In-house (Captive) (2018-2027) ($MN)
Table 87 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Product (2018-2027) ($MN)
Table 88 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biologic (2018-2027) ($MN)
Table 89 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biosimilar (2018-2027) ($MN)
Table 90 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biotech (2018-2027) ($MN)
Table 91 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Synthetic (2018-2027) ($MN)
Table 92 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Application (2018-2027) ($MN)
Table 93 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Glaucoma (2018-2027) ($MN)
Table 94 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Hormonal (2018-2027) ($MN)
Table 95 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Infectious Diseases (2018-2027) ($MN)
Table 96 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Inflammation (2018-2027) ($MN)
Table 97 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Musculoskeletal Drugs (2018-2027) ($MN)
Table 98 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Oncology (2018-2027) ($MN)
Table 99 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Other Applications (2018-2027) ($MN)
Table 100 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Anti-diabetic Drugs (2018-2027) ($MN)
Table 101 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Cardiovascular Drugs (2018-2027) ($MN)
Table 102 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Cosmetology (2018-2027) ($MN)
Table 103 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Erectile Dysfunction (2018-2027) ($MN)
Table 104 Asia Pacific High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Respiratory Disorders (2018-2027) ($MN)
Table 105 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Country (2018-2027) ($MN)
Table 106 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Drug Type (2018-2027) ($MN)
Table 107 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Novel (2018-2027) ($MN)
Table 108 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Innovative (2018-2027) ($MN)
Table 109 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Generic (2018-2027) ($MN)
Table 110 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Manufacturer (2018-2027) ($MN)
Table 111 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Outsourced/ Contract (2018-2027) ($MN)
Table 112 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By In-house (Captive) (2018-2027) ($MN)
Table 113 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Product (2018-2027) ($MN)
Table 114 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biologic (2018-2027) ($MN)
Table 115 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biosimilar (2018-2027) ($MN)
Table 116 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biotech (2018-2027) ($MN)
Table 117 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Synthetic (2018-2027) ($MN)
Table 118 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Application (2018-2027) ($MN)
Table 119 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Glaucoma (2018-2027) ($MN)
Table 120 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Hormonal (2018-2027) ($MN)
Table 121 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Infectious Diseases (2018-2027) ($MN)
Table 122 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Inflammation (2018-2027) ($MN)
Table 123 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Musculoskeletal Drugs (2018-2027) ($MN)
Table 124 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Oncology (2018-2027) ($MN)
Table 125 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Other Applications (2018-2027) ($MN)
Table 126 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Anti-diabetic Drugs (2018-2027) ($MN)
Table 127 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Cardiovascular Drugs (2018-2027) ($MN)
Table 128 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Cosmetology (2018-2027) ($MN)
Table 129 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Erectile Dysfunction (2018-2027) ($MN)
Table 130 South America High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Respiratory Disorders (2018-2027) ($MN)
Table 131 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Country (2018-2027) ($MN)
Table 132 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Drug Type (2018-2027) ($MN)
Table 133 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Novel (2018-2027) ($MN)
Table 134 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Innovative (2018-2027) ($MN)
Table 135 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Generic (2018-2027) ($MN)
Table 136 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Manufacturer (2018-2027) ($MN)
Table 137 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Outsourced/ Contract (2018-2027) ($MN)
Table 138 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By In-house (Captive) (2018-2027) ($MN)
Table 139 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Product (2018-2027) ($MN)
Table 140 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biologic (2018-2027) ($MN)
Table 141 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biosimilar (2018-2027) ($MN)
Table 142 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Biotech (2018-2027) ($MN)
Table 143 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Synthetic (2018-2027) ($MN)
Table 144 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Application (2018-2027) ($MN)
Table 145 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Glaucoma (2018-2027) ($MN)
Table 146 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Hormonal (2018-2027) ($MN)
Table 147 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Infectious Diseases (2018-2027) ($MN)
Table 148 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Inflammation (2018-2027) ($MN)
Table 149 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Musculoskeletal Drugs (2018-2027) ($MN)
Table 150 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Oncology (2018-2027) ($MN)
Table 151 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Other Applications (2018-2027) ($MN)
Table 152 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Anti-diabetic Drugs (2018-2027) ($MN)
Table 153 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Cardiovascular Drugs (2018-2027) ($MN)
Table 154 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Cosmetology (2018-2027) ($MN)
Table 155 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Erectile Dysfunction (2018-2027) ($MN)
Table 156 Middle East & Africa High Potency Active Pharmaceutical Ingredient (HPAPI) Market Outlook, By Respiratory Disorders (2018-2027) ($MN)



【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[高薬理活性医薬原体（HPAPI）の世界市場2019-2027]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 造影デジタルマンモグラフィ（CEDM）の世界市場2019-2027
    SMRC20JL109 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、造影デジタルマンモグラフィ（CEDM）の世界市場について調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、画像タイプ別（2D画像、3D画像）分析、技術別分析、用途別分析、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報などを含めており、以下の構成で提供いたします。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・造影デジタルマンモグラフィ（CEDM）の世界市場規模：画像タイプ別（2D画像、3D画像） ・造影デジタルマンモグラフィ（CEDM）の世界市場規模：技術別 ・造影デジタルマンモグラフィ（CEDM）の世界市場規模：用途別 ・造影デジタルマンモグラフィ（CEDM）の世界市場規模：エンドユーザー別 ・造影デジタルマンモグラフィ（CEDM）の世界市場規模：地域別...According to Stratistics MRC, the Global Contrast-Enhanced Digital Mammography (CEDM) Market is accounted for $275.31 million in 2019 and is expected to reach $711.42 million by 2027 growing at a CAGR of 12.6% during the forecast period. The rise in the prevalence of breast cancer and the implementation of breast cancer screening programs across the world are the major factors propelling the market growth. However, generating artifacts on the subtracted images is hampering the growth of the market. The contrast-enhanced digital mammography (CEDM) is an advanced modality of breast imaging, which helps in the improvement of the breast cancer screening...
  2. 高薬理活性原薬（HPAPI）の世界市場予測（～2023年）：種類、合成、メーカー、治療分野
    MAM-PH-4897 / MarketsandMarkets / 2018年4月18日 / MarketsandMarketsが発行した当調査レポートでは、高薬理活性原薬（HPAPI）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、合成別分析、メーカー別分析、治療分野別分析、高薬理活性原薬（HPAPI）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global HPAPI market is expected to reach USD 26.84 Billion by 2023 from USD 17.72 Billion in 2018, at a CAGR 8.7%. The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine. This report segments the HPAPIs market into type, type of manufacturer, type of synthesis, therapeutic application, and region. Based on type, the HPAPI market is segmented into innovative and generic APIs. In 2018, the innovative HPAPIs segment...
  3. 超音波ジェルの世界市場2019-2027
    SMRC20JL474 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、超音波ジェルの世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、エンドユーザー別（病院、外来手術センター、クリニック、診断センター）分析、種類別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・超音波ジェルの世界市場規模：エンドユーザー別（病院、外来手術センター、クリニック、診断センター） ・超音波ジェルの世界市場規模：種類別 ・超音波ジェルの世界市場規模：地域別 ・主要な市場開拓 ・企業情報...According to Stratistics MRC, the Global Ultrasound Gels Market is accounted for $517.28 million in 2019 and is expected to reach $1,158.15 million by 2027 growing at a CAGR of 10.6% during the forecast period. Some of the key factors propelling the market growth are increasing demand from hospitals, low cost of the product, and rising awareness regarding breast cancer. However, the cooling effect of ultrasound gels is the restraining factor for the growth of the market. Ultrasound gels are the conductive medium which is generally composed of propylene glycol, water and sometimes a dye. It acts as a coupling...
  4. 組換えC因子(rFC)アッセイの世界市場2019-2027
    SMRC20JL384 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、組換えC因子(rFC)アッセイの世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、エンドユーザー別（受託研究機関（CRO）、バイオテクノロジー企業、医療機器会社、製薬会社）分析、ブランド別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・組換えC因子(rFC)アッセイの世界市場規模：エンドユーザー別（受託研究機関（CRO）、バイオテクノロジー企業、医療機器会社、製薬会社） ・組換えC因子(rFC)アッセイの世界市場規模：ブランド別 ・組換えC因子(rFC)アッセイの世界市場規模：地域別 ・主要な市場開拓 ・企業情報...According to Stratistics MRC, the Global Recombinant Factor C Assay Market is accounted for $14.29 million in 2019 and is expected to reach $30.40 million by 2027 growing at a CAGR of 9.9% during the forecast period. The rise in need of alternative endotoxin detection tests and cost advantages by helping in reducing the operator risks is propelling the market growth. However, the lack of long-term studies that validate rFC for combination testing of unknown samples is hampering the market growth. Recombinant factor C (rFC) assay is an alternative to LAL tests utilized for endotoxin testing of the products for...
  5. GAS咽頭炎診断の世界市場2019-2027
    SMRC20JL196 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、GAS咽頭炎診断の世界市場について調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、製品別（PCRベーステスト、迅速試験キット、培養検査）、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報などを含めており、以下の構成で提供いたします。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・GAS咽頭炎診断の世界市場規模：製品別（PCRベーステスト、迅速試験キット、培養検査） ・GAS咽頭炎診断の世界市場規模：エンドユーザー別 ・GAS咽頭炎診断の世界市場規模：地域別 ・主要な市場開拓 ・企業情報...According to Stratistics MRC, the Global GAS Pharyngitis Diagnostics Market is accounted for $169.88 million in 2019 and is expected to reach $232.50 million by 2027 growing at a CAGR of 4.0% during the forecast period. Incidence and prevalence of gas pharyngitis infections are gradually growing across the globe and thereby driving the growth of the market. However, issues in providing accurate, efficient, and accessible diagnostics are restraining the growth of the market. Pharyngitis is inflammation of the pharynx, which is in the backside of the throat. It is most frequently referred to simply as sore throat. Numerous viral and...
  6. 創傷閉鎖ストリップの世界市場2019-2027
    SMRC20JL508 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、創傷閉鎖ストリップの世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、種類別（強化、フレキシブル）分析、無菌性別分析、用途別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・創傷閉鎖ストリップの世界市場規模：種類別（強化、フレキシブル） ・創傷閉鎖ストリップの世界市場規模：無菌性別 ・創傷閉鎖ストリップの世界市場規模：用途別 ・創傷閉鎖ストリップの世界市場規模：地域別 ・主要な市場開拓...According to Stratistics MRC, the Global Wound Closure Strips Market is accounted for $266.63 million in 2019 and is expected to reach $531.27 million by 2027 growing at a CAGR of 9.0% during the forecast period. Rising public and private healthcare expenditure and high demand for superior medical technologies are propelling the growth of the market. However, lack of awareness and shortage of resources is hampering the market growth. Wound closure strips are porous surgical tape strips which can be utilized to lock small injuries. They are applied over the cuts in a way which pulls the skin on either...
  7. HIVセルフテストキットの世界市場2019-2027
    SMRC20JL220 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、HIVセルフテストキットの世界市場について調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、テスト発生別（第3世代、第2世代）分析、標本種類別分析、製品別分析、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報などを含めており、以下の構成で提供いたします。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・HIVセルフテストキットの世界市場規模：テスト発生別（第3世代、第2世代） ・HIVセルフテストキットの世界市場規模：標本種類別 ・HIVセルフテストキットの世界市場規模：製品別 ・HIVセルフテストキットの世界市場規模：エンドユーザー別 ・HIVセルフテストキットの世界市場規模：地域別...According to Stratistics MRC, the Global HIV Self-test Kits Market is accounted for $71.76 million in 2019 and is expected to reach $288.56 million by 2027 growing at a CAGR of 19.0% during the forecast period. Rise in prevalence of this disease across the globe and growing uptake of HIV self-testing policies and implementation are the major factors driving the market growth. However, a false-negative result of these kits is restraining the market growth. HIV Self-test Kits helps the individuals to access critically important health information, at their convenience by conducting their own HIV test using a simple oral or...
  8. 心嚢穿刺処置の世界市場2019-2027
    SMRC20JL353 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、心嚢穿刺処置の世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、疾患別（心臓病、感染症、炎症性/リウマチ、悪性腫瘍）分析、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・心嚢穿刺処置の世界市場規模：疾患別（心臓病、感染症、炎症性/リウマチ、悪性腫瘍） ・心嚢穿刺処置の世界市場規模：エンドユーザー別 ・心嚢穿刺処置の世界市場規模：地域別 ・主要な市場開拓 ・企業情報...According to Stratistics MRC, the Global Pericardiocentesis Procedures Market is accounted for $144.30 million in 2019 and is expected to reach $230.00 million by 2027 growing at a CAGR of 6.0% during the forecast period. Increase in the geriatric population and high adoption of minimally invasive surgeries for treatment of different medical conditions are the major factors propelling the market growth. However, complications and risk associated with the surgery are hampering the market growth. Pericardiocentesis is a minimally invasive surgical procedure performed to remove the excess levels of fluid accumulated in the pericardium sac around the heart. The procedure involves...
  9. バイオレメディエーション技術・サービスの世界市場2019-2027
    SMRC20JL075 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、バイオレメディエーション技術・サービスの世界市場について調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、機能種類別（実験施設内バイオレメディエーション、本来場所バイオレメディエーション）分析、技術別分析、サービス別分析、販売チャンネル別分析、用途別分析、地域別分析、主要な市場開拓、企業情報などを含めており、以下の構成で提供いたします。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・バイオレメディエーション技術・サービスの世界市場規模：機能種類別（実験施設内バイオレメディエーション、本来場所バイオレメディエーション） ・バイオレメディエーション技術・サービスの世界市場規模：技術別 ・バイオレメディエーション技術・サービスの世界市場規模：サービス別 ・バイオレメディエーション技術・サービスの世界市場規模：販売チャンネル別 ・バイオレメディエーション技術・サービスの世界市場規模：用途別...According to Stratistics MRC, the Global Bioremediation Technology & Services market is accounted for $9.13 billion in 2019 and is expected to reach $17.53 billion by 2027 growing at a CAGR of 8.5% during the forecast period. Some of the key factors propelling the market growth are augment the usage of fungus for treatment process of soil, increase in oil trading and enlarge in oil-contaminated sites. However, treatment time is typically longer are the restraining factor for the growth of the market. Bioremediation is the procedure, which uses organisms to neutralize or take away contamination from waste. This technique works...
  10. カスタム処置用トレイの世界市場2019-2027
    SMRC20JL121 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、カスタム処置用トレイの世界市場について調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、種類別（再利用可能型、使い捨て型）分析、包装種類別分析、用途別分析、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報などを含めており、以下の構成で提供いたします。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・カスタム処置用トレイの世界市場規模：種類別（再利用可能型、使い捨て型） ・カスタム処置用トレイの世界市場規模：包装種類別 ・カスタム処置用トレイの世界市場規模：用途別 ・カスタム処置用トレイの世界市場規模：エンドユーザー別 ・カスタム処置用トレイの世界市場規模：地域別...According to Stratistics MRC, the Global Customized Procedure Trays Market is accounted for $234.98 million in 2019 and is expected to reach $451.30 million by 2027 growing at a CAGR of 8.5% during the forecast period. Some of the key factors propelling the market growth are increasing healthcare expenditure, rising incidence of chronic diseases, and a growing number of geriatric population. However, the difficulty to gauge the savings that could be generated by customized procedure trays is the restraining factor for the growth of the market. A procedure tray is a pre-packaged set of medical devices, designed to provide all...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆